Belite Bio, Inc. (BLTE)
175.35
+8.10
(+4.84%)
USD |
NASDAQ |
Apr 02, 12:34
Belite Bio Market Cap : 7.236B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocugen, Inc. | 570.72M |
| ACADIA Pharmaceuticals, Inc. | 3.790B |
| Alnylam Pharmaceuticals, Inc. | 42.23B |
| Savara, Inc. | 1.173B |
| BioMarin Pharmaceutical, Inc. | 10.78B |
Market Cap Related Metrics
| PEG Ratio | -0.8085 |
| Price to Book Value | 8.953 |
| Price | 175.35 |
| Earnings Yield | -1.31% |
| PEGY Ratio | -0.8085 |